Post-marketing surveillance: a UK/European perspective

Keyphrases

• European Perspective 100%
• Post-marketing Surveillance 100%
• Randomized Controlled Trial 33%
• Trial Design 33%
• New Drugs 33%
• Regulatory Bodies 33%
• Integral Component 33%
• Adverse Drug Reaction 33%
• Drug Treatment 33%
• European Legislation 33%
• Medical Practitioners 33%
• Regulatory Approval 33%
• Postmarketing 33%
• Pharmacosurveillance 33%
• Concomitant Use 33%
• UK Legislation 33%
• Women of childbearing Potential 33%
• Post-marketing Pharmacovigilance 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Postmarketing Surveillance 100%
• Disease 33%
• Randomized Controlled Trial 33%
• Pharmacotherapy 33%
• Adverse Drug Reaction 33%
• Pharmacovigilance 33%